Latest News in the pharma Industry

All

Cambrex completes GMP manufacturing expansion in Estonia

Cambrex completes GMP manufacturing expansion in Estonia

27 May 2021

The expansion will accelerate the progression and tech transfer of projects within the early clinical development phases

Read more 
Sharp makes land acquisition to expand cGMP packaging capacity

Sharp makes land acquisition to expand cGMP packaging capacity

25 May 2021

The purchase is part of $17 million capacity expansion, which is in addition to a wider $43 million investment into the company's Pennsylvania operations

Read more 
Samsung Biologics to provide fill-finish manufacturing for Moderna COVID vaccine

Samsung Biologics to provide fill-finish manufacturing for Moderna COVID vaccine

24 May 2021

The CDMO will support the production of hundreds of millions of doses from its facility in Incheon, South Korea.

Read more 
Finding the right experts and collaborating at speed essential to COVID-19 vaccine rollout, says CPhI panel

Finding the right experts and collaborating at speed essential to COVID-19 vaccine rollout, says CPhI panel

21 May 2021

CPhI Discover webinar examines the progress made so far in terms of vaccine distribution to the global population as well as anticipating future challenges

Read more 
API market tested by COVID-19 but pandemic is accelerating adoption of supply chain solutions: CPhI panel

API market tested by COVID-19 but pandemic is accelerating adoption of supply chain solutions: CPhI panel

21 May 2021

CPhI Discover panel of industry experts discusses impact of COVID-19 on API manufacturing and trading as well as the controversial topic of reshoring production

Read more 
‘Conscious consumer’ demand is propelling cosmeceuticals industry, experts tell CPhI Discover audience

‘Conscious consumer’ demand is propelling cosmeceuticals industry, experts tell CPhI Discover audience

20 May 2021

Upstream raw materials suppliers seen as the main source of innovation in a growing industry driven by demand for more natural ingredients manufactured in clean, sustainable way

Read more 
UPDATED: The CPhI Discover Blog

UPDATED: The CPhI Discover Blog

20 May 2021

Bookmark this page for regular updates on the rich variety of content coming your way via CPhI Discover, pharma’s largest ever virtual gathering, over the course of our three-day agenda

Read more 
Pharmapack Podcast Series: Senior patient-friendly drug device design - Part Three

Pharmapack Podcast Series: Senior patient-friendly drug device design - Part Three

20 May 2021

Partnering with one of northern Europe’s oldest academic universities, Lund University in Sweden, Pharmapack has launched this three-part podcast series, delivering the latest insights on medication packaging innovation and the gathering momentum...

Read more 
Innovating in the viscosity design space with a new 2.25 mL autoinjector platform

Innovating in the viscosity design space with a new 2.25 mL autoinjector platform

19 May 2021

Extending its patient-centric BD Intevia™ Disposable Autoinjector platform, BD builds on past successes while meeting the requirements of new, highly viscous, high-volume biologics for chronic diseases

Read more 
Self-administration trend driving demand for subcutaneous drug delivery devices, says BD expert

Self-administration trend driving demand for subcutaneous drug delivery devices, says BD expert

19 May 2021

Dosing complexity means programmable devices need to address several requirements around wearability and flexibility, CPhI Discover delegates are told

Read more 
Overall benefits of ready-to-administer systems outweigh the initial cost disadvantages, says BD expert

Overall benefits of ready-to-administer systems outweigh the initial cost disadvantages, says BD expert

19 May 2021

Pre-fillable syringes for intravenous drugs can replace traditional glass vials and ampoules, particularly in the time-sensitive and fast-paced world of emergency care

Read more 
Sandoz outlines European antibiotic manufacturing expansion

Sandoz outlines European antibiotic manufacturing expansion

19 May 2021

Novartis generics and biosimilars division will invest €150 million during the next 3-5 years at its Kundl, Austria and Palafolls, Spain sites while phasing out production of oral APIs at Les Franqueses site

Read more